Advertisement
Screener

BIOMERICA INC (BMRA) Revenue, Net (Deprecated 2018-01-31)

2.8 / 5 stars · 68/120 Roast Me

BIOMERICA INC Revenue, Net (Deprecated 2018-01-31)

BIOMERICA INC (BMRA) reported Revenue, Net (Deprecated 2018-01-31) of $1.61 million for the 3-month period ending 2017-11-30, per its 10-Q filed 2018-01-17.

Discontinued › Income Statement

us-gaap:SalesRevenueNet · last filed 2018-01-17

  • BIOMERICA INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-11-30 was $1.61M, a 12.67% increase year-over-year.
  • BIOMERICA INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-08-31 was $1.44M, a 2.44% increase year-over-year.
  • BIOMERICA INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-05-31 was $1.45M, a 9.30% increase year-over-year.
  • BIOMERICA INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-02-28 was $1.50M, a 10.16% increase year-over-year.
  • BIOMERICA INC revenue, net (deprecated 2018-01-31) for fiscal 2017 was $5.79M, a 12.68% increase from fiscal 2016.
  • BIOMERICA INC revenue, net (deprecated 2018-01-31) for fiscal 2016 was $5.14M, a 3.58% increase from fiscal 2015.
  • BIOMERICA INC revenue, net (deprecated 2018-01-31) for fiscal 2015 was $4.96M, a 3.09% decline from fiscal 2014.
  • BIOMERICA INC revenue, net (deprecated 2018-01-31) for fiscal 2014 was $5.12M, a 20.89% decline from fiscal 2013.
Period endRevenue, Net (Deprecated 2018-01-31) 3 monthRevenue, Net (Deprecated 2018-01-31) 6 monthRevenue, Net (Deprecated 2018-01-31) 9 monthRevenue, Net (Deprecated 2018-01-31) 12 month
2017-11-30$1.61M
10-Q · filed 2018-01-17
$3.06M
10-Q · filed 2018-01-17
$4.51M
derived: sum of 3 quarters · filed 2018-01-17
$6.01M
derived: sum of 4 quarters · filed 2018-01-17
2017-08-31$1.44M
10-Q · filed 2017-10-16
$2.89M
derived: sum of 2 quarters · filed 2017-10-16
$4.39M
derived: sum of 3 quarters · filed 2017-10-16
$5.83M
derived: sum of 4 quarters · filed 2018-01-17
2017-05-31$1.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-29
$2.95M
derived: sum of 2 quarters · filed 2017-08-29
$4.38M
derived: sum of 3 quarters · filed 2018-01-17
$5.79M
10-K · filed 2017-08-29
2017-02-28$1.50M
10-Q · filed 2017-04-14
$2.93M
derived: sum of 2 quarters · filed 2018-01-17
$4.34M
10-Q · filed 2017-04-14
$5.67M
derived: sum of 4 quarters · filed 2018-01-17
2016-11-30$1.43M
10-Q · filed 2018-01-17
$2.84M
10-Q · filed 2018-01-17
$4.17M
derived: sum of 3 quarters · filed 2018-01-17
$5.53M
derived: sum of 4 quarters · filed 2018-01-17
2016-08-31$1.41M
10-Q · filed 2017-10-16
$2.74M
derived: sum of 2 quarters · filed 2017-10-16
$4.10M
derived: sum of 3 quarters · filed 2017-10-16
$5.26M
derived: sum of 4 quarters · filed 2017-10-16
2016-05-31$1.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-29
$2.69M
derived: sum of 2 quarters · filed 2017-08-29
$3.85M
derived: sum of 3 quarters · filed 2017-08-29
$5.14M
10-K · filed 2017-08-29
2016-02-29$1.36M
10-Q · filed 2017-04-14
$2.53M
derived: sum of 2 quarters · filed 2017-04-14
$3.81M
10-Q · filed 2017-04-14
$5.31M
derived: sum of 4 quarters · filed 2017-04-14
2015-11-30$1.17M
10-Q · filed 2017-01-17
$2.45M
10-Q · filed 2017-01-17
$3.95M
derived: sum of 3 quarters · filed 2017-01-17
$5.25M
derived: sum of 4 quarters · filed 2017-01-17
2015-08-31$1.29M
10-Q · filed 2016-10-17
$2.78M
derived: sum of 2 quarters · filed 2016-10-17
$4.08M
derived: sum of 3 quarters · filed 2016-10-17
$5.21M
derived: sum of 4 quarters · filed 2016-10-17
2015-05-31$1.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29
$2.79M
derived: sum of 2 quarters · filed 2016-08-29
$3.93M
derived: sum of 3 quarters · filed 2016-08-29
$4.96M
10-K · filed 2016-08-29
2015-02-28$1.30M
10-Q · filed 2016-04-14
$2.43M
derived: sum of 2 quarters · filed 2016-04-14
$3.47M
10-Q · filed 2016-04-14
$5.15M
derived: sum of 4 quarters · filed 2016-04-14
2014-11-30$1.13M
10-Q · filed 2016-01-14
$2.17M
10-Q · filed 2016-01-14
$3.85M
derived: sum of 3 quarters · filed 2016-01-14
$5.34M
derived: sum of 4 quarters · filed 2016-01-14
2014-08-31$1.03M
10-Q · filed 2015-10-15
$2.71M
derived: sum of 2 quarters · filed 2015-10-15
$4.21M
derived: sum of 3 quarters · filed 2015-10-15
$5.14M
derived: sum of 4 quarters · filed 2015-10-15
2014-05-31$1.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31
$3.17M
derived: sum of 2 quarters · filed 2015-08-31
$4.11M
derived: sum of 3 quarters · filed 2015-08-31
$5.12M
10-K · filed 2015-08-31
2014-02-28$1.49M
10-Q · filed 2015-04-14
$2.43M
derived: sum of 2 quarters · filed 2015-04-14
$3.44M
10-Q · filed 2015-04-14
$4.91M
derived: sum of 4 quarters · filed 2015-04-14
2013-11-30$934.84K
10-Q · filed 2015-01-14
$1.95M
10-Q · filed 2015-01-14
$3.42M
derived: sum of 3 quarters · filed 2015-01-14
$4.84M
derived: sum of 4 quarters · filed 2015-01-14
2013-08-31$1.01M
10-Q · filed 2014-10-15
$2.48M
derived: sum of 2 quarters · filed 2014-10-15
$3.90M
derived: sum of 3 quarters · filed 2014-10-15
$5.78M
derived: sum of 4 quarters · filed 2014-10-15
2013-05-31$1.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29
$2.89M
derived: sum of 2 quarters · filed 2014-08-29
$4.77M
derived: sum of 3 quarters · filed 2014-08-29
$6.47M
10-K · filed 2014-08-29
2013-02-28$1.42M
10-Q · filed 2014-04-14
$3.30M
derived: sum of 2 quarters · filed 2014-04-14
$5.00M
10-Q · filed 2014-04-14
$6.54M
derived: sum of 4 quarters · filed 2014-04-14
2012-11-30$1.88M
10-Q · filed 2014-01-14
$3.59M
10-Q · filed 2014-01-14
$5.13M
derived: sum of 3 quarters · filed 2014-01-14
$6.64M
derived: sum of 4 quarters · filed 2014-01-14
2012-08-31$1.70M
10-Q · filed 2013-10-15
$3.24M
derived: sum of 2 quarters · filed 2013-10-15
$4.76M
derived: sum of 3 quarters · filed 2013-10-15
$6.38M
derived: sum of 4 quarters · filed 2013-10-15
2012-05-31$1.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29
$3.06M
derived: sum of 2 quarters · filed 2013-08-29
$4.67M
derived: sum of 3 quarters · filed 2013-08-29
$6.08M
10-K · filed 2013-08-29
2012-02-29$1.51M
10-Q · filed 2013-04-15
$3.13M
derived: sum of 2 quarters · filed 2013-04-15
$4.54M
10-Q · filed 2013-04-15
$5.75M
derived: sum of 4 quarters · filed 2013-04-15
2011-11-30$1.62M
10-Q · filed 2013-01-14
$3.02M
10-Q · filed 2013-01-14
$4.24M
derived: sum of 3 quarters · filed 2013-01-14
$5.59M
derived: sum of 4 quarters · filed 2013-01-14
2011-08-31$1.41M
10-Q · filed 2012-10-12
$2.62M
derived: sum of 2 quarters · filed 2012-10-12
$3.97M
derived: sum of 3 quarters · filed 2012-10-12
$5.13M
derived: sum of 4 quarters · filed 2012-10-12
2011-05-31$1.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29
$2.56M
derived: sum of 2 quarters · filed 2012-08-29
$3.72M
derived: sum of 3 quarters · filed 2012-08-29
$4.90M
10-K · filed 2012-08-29
2011-02-28$1.35M
10-Q · filed 2012-04-16
$2.51M
derived: sum of 2 quarters · filed 2012-04-16
$3.68M
10-Q · filed 2012-04-16
2010-11-30$1.16M
10-Q · filed 2012-01-17
$2.34M
10-Q · filed 2012-01-17
2010-08-31$1.18M
10-Q/A · filed 2011-10-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92